| Drug Type Small molecule drug, Probiotics | 
| Synonyms ProbiomeC, 프로바이옴씨캡슐 | 
| Target- | 
| Action- | 
| Mechanism- | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date South Korea (20 Mar 2025),  | 
| Regulation- | 
| Molecular FormulaC18H34CaN2O10 | 
| InChIKeyWIWQIMNDNVAWQN-UBKPKTQASA-N | 
| CAS Registry137-08-6 | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Abdomen distended | South Korea  | 20 Mar 2025 | |
| Constipation | South Korea  | 20 Mar 2025 | |
| Diarrhea | South Korea  | 20 Mar 2025 | |
| Dyspepsia | South Korea  | 20 Mar 2025 | 





